NBGI acquires Stiplastics

Equity for the Stiplastics investment was sourced from NBGI Private Equity France Fund I.

The deal was initiated through the prior relationship between NBGI and Stiplastics's founder.

Company
Stiplastics is a manufacturer of plastic products, focused on the production of injection-moulded plastic dosing, packaging solutions and packaging for the pharmaceuticals industry. Its client base includes Novartis, Sanofi Aventis and Danone.

Stiplastics is headquartered in Beauvoir en Royans and employs 70 people. In 2012, the company's revenues amounted to €12.5m. According to the new strategy, sales are expected to increase to €23m by 2017 through new projects. Stiplastics generates more than half of its sales outside of France.

People
Investment director Laurent Allegot led the deal on behalf of NBGI. Jerome Empereur is CEO of Stiplastics.

Advisers
Equity – HPML (Legal); Audexo (Financial due diligence); PwC (Commercial due diligence). 

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• France
• Industrials
• Buyouts
• NBGI Private Equity
• France